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These deﬁ ciencies might be common 
to most countries in Asia, making them 
vulnerable to the ongoing yellow fever 
epidemic. The data show that tourists 
entering Sri Lanka from selected west 
African and South American countries, 
especially via irregular routes, pose 
the highest risk of infection. However, 
the cases of yellow fever in China were 
mainly from returning Chinese migrant 
workers from Angola. Information 
on the yellow fever vaccination status 
of these populations might not be 
available in many countries because 
of gaps in registration and surveillance 
systems. Without these data, risk 
assessment would be partial and 
inaccurate. 
With the emerging threat of yellow 
fever and increasing global migration 
trends, non-endemic countries with 
high densities of A aegypti might 
be better prepared for possible 
yellow fever outbreaks through the 
establishment or enhancement of 
border health information systems, 
surveillance, and regulatory capacities. 
State parties to the International Health 
Regulations4 are required to develop 
and maintain capacities to respond 
to public health events at points of 
entry. Assessing the vaccination status 
of travellers when they arrive from, 
or depart to, yellow fever-endemic 
countries remains crucial. At the time 
of writing, following the yellow fever 
outbreak in Angola, the Directorate 
of Quarantine and Epidemiological 
Unit of the Ministry of Health, in 
partnership with airport authorities, are 
establishing such measures. 
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Is Sri Lanka prepared for 
yellow fever outbreaks? 
A case study
From Dec 5, 2015 to Oct 13, 2016, 
4306 suspected cases of yellow 
fever were reported in Angola, with 
369 deaths and an alarming case 
fatality ratio of 8·8%.1 Three countries: 
the Democratic Republic of the Congo, 
Kenya, and China, have reported 
imported cases from Angola. This is 
the ﬁ rst time yellow fever has been 
reported in Asia. Of the ten laboratory-
confirmed yellow fever cases 
reported in China, six people reside 
in Fujian Province, an area where 
dengue transmission has occurred, 
raising concerns of autochthonous 
transmission.2 In response to global 
concerns about the spread of yellow 
fever and the ﬁ rst cases reported in 
Asia,3 we analysed the border health 
procedures pertaining to yellow fever 
vaccination and epidemiological 
surveillance, regulation, and control 
in Sri Lanka as a case study for other 
non-endemic countries, particularly 
those in Asia with an abundance of the 
vector Aedes aegypti.
We captured yellow fever vaccination 
data from the traveller vaccination 
unit of the Medical Research Institute, 
the only certified centre where 
outbound travellers can receive the 
pre-departure yellow fever vaccine; 
and the Port Medical Office located 
at Colombo seaport, which provides 
yellow fever vaccines to maritime 
travellers. To determine the volume 
and dynamics of inbound migrants and 
travellers from yellow fever-endemic 
countries, data from the Sri Lanka 
Tourism Development authority 
and the Department of Immigration 
and Emigration databases were 
analysed. We examined information 
from the International Organization 
for Migration database, specifically 
information about assisted voluntary 
returnees to Sri Lanka from yellow 
fever-endemic countries.  We 
conducted interviews with medical 
staﬀ  from the vaccination centre at the 
Medical Research Institute, the Ministry 
of Health’s Directorate of Quarantine, 
and border control authorities to 
determine routine practice, record-
keeping, and standard operational 
procedures pertaining to yellow fever 
vaccination at points of entry.
28 684 yellow fever vaccinations 
were administered to travellers from 
Sri Lanka during a 13-year period 
(1998–2011). The destinations of Sri 
Lankan travellers who obtained yellow 
fever vaccines were primarily in Africa 
(97%). The number of tourists to Sri 
Lanka from yellow fever-endemic 
countries increased from 911 in 
2009 to 1380 in 2011, with Kenya, 
Nigeria, and Zambia contributing 
most. No disaggregated data on place 
of destination and duration of visit 
was available for both inbound and 
outbound travellers, and no records 
on the international certificate of 
vaccination or prophylaxis against 
yellow fever were available for 
inbound travellers. The International 
Organization for Migration database 
showed the return of 534 Sri Lankans 
from eight west African nations of 
Togo, Benin, Guinea, Sierra Leone, 
Mali, Ghana, Senegal, and Mauritania, 
during this period. All were so-called 
irregular migrants, part of a human 
smuggling operation. The average 
duration of stay in West Africa was 
20·5 weeks. On arrival in Sri Lanka, 98% 
of these returnees had the yellow fever 
vaccination. Interviews revealed that 
potentially three of every ﬁ ve people 
seeking yellow fever vaccination would 
depart within a week of receiving 
the inoculation, contrary to national 
vaccination guidelines. There were no 
standard operational procedures, or 
monitoring or regulatory mechanisms 
that enabled Sri Lankan immigration 
authorities or port health officers 
to check yellow fever certification. 
Traveller declaration forms for both 
arrival and disembarkation make no 
reference to vaccination requirements 
for yellow fever or other infectious 
diseases. 
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